Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
J Small Anim Pract ; 59(5): 286-293, 2018 May.
Artigo em Inglês | MEDLINE | ID: mdl-29280490

RESUMO

OBJECTIVES: To evaluate doxycycline treatment efficacy and post-treatment pathogen persistence in dogs naturally infected with Anaplasma phagocytophilum in endemic regions of the USA. MATERIALS AND METHODS: Symptomatic dogs in four US states (MN, WI, CT and CA) were evaluated before treatment with doxycycline and approximately 30 and 60 days post-treatment. Clinicopathological parameters, co-exposures and A. phagocytophilum DNA in whole blood and lymph node samples were compared between A. phagocytophilum infected and uninfected dogs. RESULTS: In total, 42 dogs fulfilled the inclusion criteria, with 16 dogs (38%) blood PCR-positive and 26 dogs (62%) blood PCR-negative for A. phagocytophilum. At initial evaluation, the proportion of clinicopathological abnormalities was similar between A. phagocytophilum infected and uninfected dogs, although thrombocytopenia and lymphopenia were statistically more prevalent among A. phagocytophilum infected dogs. Treatment with doxycycline resulted in resolution of all clinical abnormalities in infected dogs; four dogs had persistent haematological abnormalities, including mild leukopenia, eosinopenia and lymphopenia. All 16 infected dogs became blood PCR-negative approximately 30 and 60 days after treatment onset. Additionally, 13/13 (100%) lymph node specimens tested post-treatment were PCR-negative. Select clinicopathological abnormalities persisted in uninfected dogs after treatment. CLINICAL SIGNIFICANCE: The results of this study support the efficacy of doxycycline therapy for clinical treatment of dogs naturally infected with A. phagocytophilum in the USA. This study did not find clinical, haematological or microbiological indicators that supported the persistence of A. phagocytophilum infection in naturally infected dogs following treatment with doxycycline for 28 days.


Assuntos
Anaplasma phagocytophilum/efeitos dos fármacos , Antibacterianos/uso terapêutico , Doenças do Cão/tratamento farmacológico , Doxiciclina/uso terapêutico , Anaplasma phagocytophilum/genética , Animais , Antibacterianos/administração & dosagem , DNA Bacteriano/sangue , DNA Bacteriano/isolamento & purificação , Doenças do Cão/microbiologia , Cães , Doxiciclina/administração & dosagem , Ehrlichiose/veterinária , Linfonodos/microbiologia , Reação em Cadeia da Polimerase/veterinária , Estados Unidos
3.
J Vet Intern Med ; 28(6): 1702-7, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-25274547

RESUMO

BACKGROUND: Frequent exposure of Grenadian dogs to Rhipicephalus sanguineus results in Anaplasma platys, and Ehrlichia canis seroreactivity. During elective surgeries, substantial intraoperative hemorrhage occurs in some seroreactive dogs. OBJECTIVES: To assess hemostatic parameters and bleeding tendencies as well as prevalence of PCR positivity in apparently healthy A. platys and E. canis seroreactive and seronegative free-roaming dogs from Grenada. ANIMALS: Forty-seven elective surgery dogs allocated to 4 groups: Seronegative control (n = 12), A. platys (n = 10), E. canis (n = 14) and A. platys, and E. canis (n = 11) seroreactive. METHODS: Preoperatively, hemostasis was assessed by platelet count, prothrombin time, activated partial thromboplastin time, and buccal mucosal bleeding time. Intra- and postoperative bleeding scores were subjectively assigned. Blood, spleen, bone marrow, and lymph node aspirates were tested by PCR. RESULTS: Bleeding scores in dogs coseroreactive for A. platys and E. canis were higher (P = .015) than those of seronegative dogs. A. platys DNA was amplified from 7/21 (33%) A. platys seroreactive dogs and from 1 E. canis seroreactive dog; E. canis DNA was amplified from 21/25 (84%) E. canis seroreactive dogs. E. canis DNA was amplified most often from blood, whereas A. platys DNA was amplified most often from bone marrow. CONCLUSIONS AND CLINICAL IMPORTANCE: Apparently healthy, free-roaming dogs coseropositive for A. platys and E. canis may have increased intraoperative bleeding tendencies despite normal hemostatic parameters. Future investigations should explore the potential for vascular injury as a cause for bleeding in these dogs. Improved tick control is needed for dogs in Grenada.


Assuntos
Anaplasma , Anaplasmose/complicações , Perda Sanguínea Cirúrgica/veterinária , Doenças do Cão/microbiologia , Ehrlichia canis , Ehrlichiose/veterinária , Anaplasmose/sangue , Anaplasmose/epidemiologia , Animais , Doenças do Cão/sangue , Doenças do Cão/epidemiologia , Doenças do Cão/etiologia , Cães , Ehrlichiose/sangue , Ehrlichiose/complicações , Ehrlichiose/epidemiologia , Feminino , Granada/epidemiologia , Masculino , Tempo de Tromboplastina Parcial/veterinária , Contagem de Plaquetas/veterinária , Tempo de Protrombina/veterinária
5.
Vet Comp Oncol ; 9(3): 196-206, 2011 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-21848622

RESUMO

Canine mammary gland tumours (CMTs) are the most common malignancies in female dogs. The receptor tyrosine kinase EGFR (erbb1), a receptor for epidermal growth factor (EGF) and related factors, mediates multiple oncogenic functions in human epithelial neoplasms. While previous studies have demonstrated EGFR expression in canine tumours, its function has not been studied in canine cancer. The purpose of this study was to determine the in vitro effects of EGF and vandetanib (ZD6474), a small molecule inhibitor of VEGFR-2, EGFR and RET tyrosine kinases, on proliferation, invasion, survival and chemosensitivity in CMT cells. In low serum, EGF enhanced proliferation and chemotaxis, attenuated apoptosis, and stimulated vascular endothelial growth factor (VEGF) production. Vandetanib dose-dependently inhibited EGFR phosphorylation as well as PI3K/Akt activation, and inhibited all EGF-induced phenotypic effects. In conclusion, EGF stimulates multiple features promoting the malignant phenotype in CMT. Thus, CMT may be an important translational model for the investigation of novel EGFR-directed therapies.


Assuntos
Doenças do Cão/tratamento farmacológico , Fator de Crescimento Epidérmico/farmacologia , Receptores ErbB/antagonistas & inibidores , Neoplasias Mamárias Animais/tratamento farmacológico , Piperidinas/farmacologia , Inibidores de Proteínas Quinases/farmacologia , Quinazolinas/farmacologia , Animais , Apoptose , Linhagem Celular Tumoral , Doenças do Cão/patologia , Cães , Feminino , Neoplasias Mamárias Animais/patologia , Fosforilação , Proteínas Proto-Oncogênicas c-akt/metabolismo , Proteínas Proto-Oncogênicas c-ret/metabolismo , Fator A de Crescimento do Endotélio Vascular/metabolismo , Receptor 2 de Fatores de Crescimento do Endotélio Vascular/metabolismo
6.
Can J Microbiol ; 47(1): 63-71, 2001 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-15049451

RESUMO

Azotobacter vinelandii contains two superoxide dismutases (SODs), a cytoplasmic iron-containing enzyme (FeSOD), and a periplasmic copper/zinc-containing enzyme (CuZnSOD). In this study, the FeSOD was found to be constitutive, while the activity of CuZnSOD increased as the culture entered the stationary phase. Total SOD (units/mg protein) in stationary phase cells grown under nitrogen-fixing conditions was not significantly different from those grown under non-nitrogen-fixing conditions. The gene encoding FeSOD (sodB) was isolated from an A. vinelandii cosmid library. A 1-kb fragment containing the coding region and 400 base pairs of upstream sequence was cloned and sequenced. The nucleotide sequence and the deduced amino acid sequence had a high degree of homology with other bacterial FeSODs, particularly with P. aeruginosa. Attempts to construct a sodB mutant by recombination of a sodB::kan insertion mutation into the multicopy chromosome of A. vinelandii were unsuccessful even in the presence of SOD mimics or nutritional supplements. These results suggest that FeSOD may be essential for the growth and survival of A. vinelandii, and that the periplasmic CuZnSOD cannot replace the function of FeSOD.


Assuntos
Azotobacter vinelandii/enzimologia , Proteínas de Bactérias/genética , Proteínas de Bactérias/metabolismo , Superóxido Dismutase/genética , Superóxido Dismutase/metabolismo , Sequência de Aminoácidos , Azotobacter vinelandii/genética , Proteínas de Bactérias/química , Sequência de Bases , Clonagem Molecular , DNA Bacteriano/química , DNA Bacteriano/isolamento & purificação , Deleção de Genes , Genes Bacterianos , Genes Essenciais , Dados de Sequência Molecular , Mutagênese Insercional , Pseudomonas aeruginosa/genética , Análise de Sequência de DNA , Homologia de Sequência , Superóxido Dismutase/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA